Moody's Ratings has downgraded Edgewell Personal Care Co's corporate family rating to B1 from Ba3, citing elevated leverage, modest free cash flow and persistent profitability headwinds. The agency revised Edgewell's outlook to stable from negative, signaling the consumer products maker may be reaching an operational turning point after a period of heavy restructuring. The downgrade reflects a balance sheet burdened by debt-to-EBITDA leverage that reached 9.2x on a Moody's-adjusted basis, driven higher by restructuring expenses and costs linked to consolidating its wet shave manufacturing network. While management affirmed its full-year guidance after returning to modest organic sales growth in North America during the third quarter of 2026, credit analysts expect leverage to remain elevated in the 6x range through 2027 even as earnings recover. Edgewell's portfolio reshaping, headlined by the February 2026 sale of its lower-margin Feminine Care division, has provided a substantial liquidity cushion, though stranded costs continue to weigh on short-term profitability, and Moody's called ongoing dividend payments and share repurchases aggressive financial policy given current debt levels. The stable outlook hinges on profitability expanding as transformation initiatives take hold, with an upgrade requiring debt-to-EBITDA leverage below 4.5x alongside sustained organic revenue growth, while a failure to bring leverage below 5.5x could trigger further negative rating actions.
Edgewell Personal Care CoMoody's downgraded Edgewell's corporate family rating to B1 from Ba3 on elevated leverage (9.2x), modest free cash flow and profitability headwinds.
